M&A: To Deal or Not to Deal

In a capital constrained environment, some might argue that now is not the time for businesses to be pursuing growth via M&A. Others might posit that the best deals are struck at weak points in the economic cycle. Senior Editor Jacob Ambrose Willson asks Criticaleye Members for their views on executing M&A in 2023 and beyond.

Featuring Commentary From:

Michel Driessen, Senior Partner, Strategy and Transactions, EY
Alastair Mills, Managing Director & Head of European Business Services, H.I.G. Capital
Michael Teixeira, CEO, MVF
Helen Wiseman, Chair, Elixinol Wellness




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Turnaround and Transformation...

Companies in many regions remain mired in challenges driven by the rapid rise in the cost of capital. Criticaleye Partner AlixPartners' 19th Annual Turnaround and Transformation Survey sees more than 700 of the worl...

Click here to download this insight
Transforming Performance Thro...

Data and analytics giant Experian drives growth through a dual focus on innovation and its workforce. Chief People Officer Jacky Simmonds speaks to Criticaleye Senior Editor Bridgette Hall about how the company leverage...

Criticaleye Asia Podcast - Be...

Till delves into the crucial role of CPO in steering business transformation, the nuances of leadership during times of crisis, and the dynamics of effective CPO partnerships with CEOs and Boards. His insights provide i...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,529




Google Bunzl plc Amazon UK Salesforce LDC Mayborn Group Redwood Bank Workday Eton Bridge Partners Legal & General Investment Management GlaxoSmithKline plc NATS Royal London Group Robert Walters London Stock Exchange E.ON UK Lightsource bp AlixPartners Tullow Oil plc Eightfold AI Accenture Veolia Water Technologies Experian Drax Group plc Concentrix